Semaglutide is a GLP-1 (Glucagon-Like Peptide-1) receptor agonist that mimics a natural hormone in the body
A side effect that is a minor nuisance for one person might be quite frustrating for another
Genome-wide analysis in over 1 million individuals of European ancestry yields improved polygenic risk scores for blood pressure traits
SURMOUNT-4 and STEP trials reveal around two-thirds of GLP-1induced weight loss returns within a year, mirroring normalized regain rates in diet-exercise studies
Postmortem analyses of Alzheimers disease brain tissue reveal abnormal aquaporin-4 expression and mislocalization, supporting a bidirectional relationship between impaired glymphatic clearance and A accumulation that accelerates brain aging and cellular degeneration (Zeppenfeld et al., 2017
Five PROM experts, four sexuality experts, and five language experts rated the quality of the three translations (human, ChatGPT3.5, and DeepL), presented in a blinded and random order